• Biomarker commercialization tools (BIC Tools) support and guide the highly regulated and strict development phases of the in-vitro diagnostics (IVD) applicable biomarker development process
• Tools are intended for academic researchers, SMEs, and technology transfer organizations (TTOs) and are available at biomarker.nu
• BIC Tools cover clinical, regulatory, and business aspects of the commercialization process

The life science industry is going through a technological transition. In the future, new innovations are expected in areas where individualized medical science, elderly care, digital services, genetics, and preventive health care meet. Here, biomarkers play a crucial role.

Kemian ja bioteknologia-alan ammattitapahtuma ChemBio Finland korostaa ohjelmasisällöissään kestävää kasvua sekä kemian ja bioteknologian tarjoamia ratkaisuja hyvinvointiin. ChemBio Finland järjestetään Helsingissä Messukeskuksessa 27.–28.4.2021.

Applied Genetic Technologies Corporation (AGTC), Blueprint Genetics, and Foundation Fighting Blindness, announce today that AGTC, a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, will join the My Retina Tracker® Program as a new scientific collaborator to enhance development of  its investigational gene therapies for inherited retinal diseases (IRDs). The My Retina Tracker® Program, a collaboration between Blueprint Genetics, Foundation Fighting Blindness and InformedDNA, is an open access, no-cost program that offers individuals with IRDs easy access to high-quality genetic diagnostics and genetic counseling. This program has become one of the largest volume genetic testing initiatives for IRDs globally.